泰德医药2025中期报告
2公司資料4財務摘要5業務摘要6管理層討論及分析20企業管治及其他資料27獨立審閱報告28中期簡明綜合損益表29中期簡明綜合全面收益表30中期簡明綜合財務狀況表32中期簡明綜合權益變動表33中期簡明綜合現金流量表36中期簡明綜合財務資料附註55釋義58技術詞彙表 Cheng Tao 6501-11 于常海 1269 18346 H 183171712-1716 21 Davis Polk & Wardwell3A 97927 1218 3880 medtideinc.com 3850 20252024CRDMOTides 20256 CRDMO50 TidesGLP-1 20251ISO 22716:200720253API TidesCRDMO2025630520202463014.5% (2)CROCDMO TIDES CRDMO CRDMOTIDES CRDMO •2024630197.528.5%2025630253.8•2024630107.444.3%2025630155.0•202463050.6101.7%2025630102.0•(1)202463090.614.9%2025630104.1•CDMO20246303322025630338 (1)(i)(ii)(iii) CRDMO(i)CRONCE(ii)CDMOCMCAPIAPI50CMC (1) API CDMO 20256306140% •OmniPeptSynth™ •PeptiConjuX™PeptiNuclideLinkTech™PeptiConjuX™PeptiNuclideLinkTech™APIPeptiConjuX™NPeptiNuclideLinkTech™ •GreenSynth Innovations™GreenSynth Innovations™ •Impurity Screening™ GreenPepisolate™DisulfideDetect™GreenPepisolate™DisulfideDetect™ 2025630100GMPFDAGMPMFDSEMATGAGMPGMPISO9001ISO13485 17 APIcGMP20,000API50030100117 20256303,000SPPS DCAT2025SwissBiotech DayRNALeaders Europe CongressTIDES Asia 2025 TIDES USA CPHI China 2025International Oligonucleotidesand Peptides Conference (IOPC) 2025GLP-1Wegovy1,127.56166.83Keytruda1522025147.3202389520322,61212.6%GLP-1202338920321,29914.3% GLP-12025630338CDMONCEGLP-1GLP-1 CRDMO 2025300APIGMP 20256303,000SPPS2025500API1,000 API100GLP-1 TIDESGLP-1 TIDESGLP-1PDC RDCPOCCMCDMF 2025630253.82024630197.528.5%FFSFTE 2025630FFS232.92024630192.920.7%CDMO 2025630CRO55.6202463047.616.7%FTE 2025630CDMO198.22024630149.632.5% 202563098.8202463090.19.7% 2025630155.02024630107.444.3% 202563061.1%202463054.4%6.7 202463042.960.4%202563017.0202462024 202563018.6202463017.37.5% 202563040.5202463038.35.7% 202563012.7202463013.02.3% 202563013.720246307.92025630 202563018.5202463021.7 2025630102.0202463050.6 (i)(ii)(iii) 20252024630 2025630 2025630998.420241231387.2 202563020256305% 2025630 2025630 20256305202024630454202563071.1202463064.4 202563050.020256302.60%2.70% 202563017.1%2024123172.8% 2025630 2025630 2025630 2025630 2025630520491297015202563054%46%2025630 202563071.1202463064.4 26 13.2013.2113.22 13.2013.2113.22 2020611H20256302025630H30.6016,800,0001.00H428.77 2020611H2025630 2C.2.1(1)(2)(3)(4) C3 13.51B(1) 3.213.10(2)3.21 2025630 2410202563034 2025630 2025630428.772025630 2025630 2025630XV(i)XV78(ii)352(iii) (1)L2025630141,800,00073,598,888H68,201,112 (2)HealthyAngelHealthyAngelHealthyAngel 99%1% (3) 10,273,5007.25% (4) 2025630XV23XV336 (1)L2025630141,800,00073,598,888H68,201,112 (5)46%75% 49.05% (6)(i)0.1%(ii)80%(iii)19.9% 2025630XV23336 202012202111202211 2025630 28542025630343434 2410 34 2025829 1. 202061120232106501-11 CRDMO 2. 2025630342025620 3. 20241231 21 21 4. (a) 4. 10% 5. 5. 6. 7. 8. 25% 20212021202315%20232024202615% 8. 2,000,0008.25%16.5% 21%8.84% 9. 20252024630 10. 2024630 10. 11. 202563010,140,000202463015,966,000 2025630251,0002024630157,00086,0002024630151,000 12. 13. 15. CRDMO 16. 202112A100,000,0005,228,758A370,000,00022.5016,444,444AAA202562030 16. 20245152024531(i)(ii)20261231 20256302024515A621,342,000 OPM 17. 202563030.6016,800,0001.00 18. 202012202020211120221110,273,5003.894.00 18. (1)(2)30%30%40% 202520246302,311,0002,132,000 2025630202412311.512.01 19. 20. (a) 202563064.25% 20. (b) 20. (d) 21. 21. 15 2025630 21. 20241231 2024630 22. 2025630 23. 2025829
